Events

Alerte De Sécurité sur Lotus Valve System

Selon Department of Health, ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Hong Kong qui a été fabriqué par Boston Scientific.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • Date
    2016-08-04
  • Date de publication de l'événement
    2016-08-04
  • Pays de l'événement
    Hong Kong
  • Source de l'événement
    DH
  • URL de la source de l'événement
    https://www.mdco.gov.hk/english/safety/recalls/recalls_20160804a.html
  • Notes / Alertes
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notes supplémentaires dans les données
    Medical Device Safety Alert
  • Cause
    Medical device safety alert: boston scientific lotus valve system medical device manufacturer, boston scientific, has issued a medical device safety alert concerning its lotus valve system [upn: h749ltv230, h749ltv250, h749ltv270, h749ltvr3cl230, h749ltvr3cl250, h749ltvr3cl270]. the manufacturer is implementing a voluntary fsca for the lotus valve system to remove units from the field that were manufactured prior to a component related change made in march 2016. products manufactured after the implementation of this change are not impacted. there is no additional safety issue for patients who previously received a lotus implant since the issue only involves the delivery system and is not related to the performance of the implanted valve. according to the manufacturer, this action is related to a release mandrel breaks. the release mandrel is a component of the delivery system that is connected to the release pin which facilitates release of the valve from the delivery system. the manufacturer has not received any reports of release mandrel breaks for units built after the component change in march 2016. there was a number of release mandrel breaks reported for product manufactured prior to the component change. the most common outcome was resheating and removing the device without difficulty, resulting in procedural prolongation. however, the most severe outcome was catastrophic vessel trauma associated with patient death, which was reported in three cases. the manufacturer is now taking action to remove all units from the field that were manufactured prior to the change. the affected users are instructed to quarantine the affected products. according to the local supplier, the affected products are not distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 4 august 2016.

Device

Lotus Valve System
  • Modèle / numéro de série
  • Description du dispositif
    Medical Device Safety Alert: Boston Scientific Lotus Valve System
  • Manufacturer
    Boston Scientific

Manufacturer

Boston Scientific
  • Société-mère du fabricant (2017)
    Boston Scientific
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    DH